Positive News SentimentPositive NewsNASDAQ:NTRB Nutriband (NTRB) Stock Price, News & Analysis $5.78 -0.35 (-5.71%) Closing price 04/1/2025 03:58 PM EasternExtended Trading$5.81 +0.03 (+0.52%) As of 04/1/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Nutriband Stock (NASDAQ:NTRB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Nutriband alerts:Sign Up Key Stats Today's Range$5.60▼$6.2150-Day Range$5.78▼$9.9052-Week Range$3.20▼$11.78Volume24,636 shsAverage Volume76,510 shsMarket Capitalization$64.19 millionP/E RatioN/ADividend YieldN/APrice Target$13.00Consensus RatingBuy Company OverviewNutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.Read More… Remove Ads Nutriband Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks66th Percentile Overall ScoreNTRB MarketRank™: Nutriband scored higher than 66% of companies evaluated by MarketBeat, and ranked 358th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingNutriband has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageNutriband has only been the subject of 1 research reports in the past 90 days.Read more about Nutriband's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Nutriband are expected to grow in the coming year, from ($0.60) to ($0.56) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nutriband is -8.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nutriband is -8.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNutriband has a P/B Ratio of 7.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Nutriband's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.35% of the float of Nutriband has been sold short.Short Interest Ratio / Days to CoverNutriband has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutriband has recently decreased by 20.95%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNutriband does not currently pay a dividend.Dividend GrowthNutriband does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted4.35% of the float of Nutriband has been sold short.Short Interest Ratio / Days to CoverNutriband has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nutriband has recently decreased by 20.95%, indicating that investor sentiment is improving significantly. News and Social Media3.1 / 5News Sentiment1.60 News SentimentNutriband has a news sentiment score of 1.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Nutriband this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for NTRB on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Nutriband to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nutriband insiders have not sold or bought any company stock.Percentage Held by Insiders54.09% of the stock of Nutriband is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 19.70% of the stock of Nutriband is held by institutions.Read more about Nutriband's insider trading history. Receive NTRB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter. Email Address NTRB Stock News HeadlinesNutriband receives Certificate of Registration from USPTO for trademarkFebruary 21, 2025 | markets.businessinsider.comNutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.February 21, 2025 | globenewswire.comTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 2, 2025 | Porter & Company (Ad)Noble Financial Sticks to Its Buy Rating for Nutriband (NTRB)February 14, 2025 | markets.businessinsider.comNutriband partners with Kindeva for opioid patch developmentFebruary 13, 2025 | msn.comNutriband, Kindeva Drug Delivery formalize exclusive development partnershipFebruary 13, 2025 | markets.businessinsider.comNutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl PatchFebruary 13, 2025 | globenewswire.comNutriband Inc. Announces Olympian Anastasia Nichita to Advisory BoardFebruary 11, 2025 | markets.businessinsider.comSee More Headlines NTRB Stock Analysis - Frequently Asked Questions How have NTRB shares performed this year? Nutriband's stock was trading at $4.71 on January 1st, 2025. Since then, NTRB stock has increased by 22.7% and is now trading at $5.78. View the best growth stocks for 2025 here. How were Nutriband's earnings last quarter? Nutriband Inc. (NASDAQ:NTRB) posted its earnings results on Tuesday, December, 3rd. The company reported ($0.12) earnings per share for the quarter. Nutriband had a negative net margin of 338.51% and a negative trailing twelve-month return on equity of 54.49%. When did Nutriband's stock split? Nutriband's stock split on Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly minted shares were payable to shareholders after the market closes on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split. How do I buy shares of Nutriband? Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nutriband own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nutriband investors own include Jiuzi (JZXN), AMC Entertainment (AMC), Aridis Pharmaceuticals (ARDS), Avenue Therapeutics (ATXI), Esports Entertainment Group (GMBL), Moleculin Biotech (MBRX) and ARMOUR Residential REIT (ARR). Company Calendar Last Earnings12/03/2024Today4/01/2025Next Earnings (Estimated)4/29/2025Fiscal Year End1/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:NTRB CIK1676047 Webnutriband.com Phone(407) 377-6695FaxN/AEmployees10Year FoundedN/APrice Target and Rating Average Stock Price Target$13.00 High Stock Price Target$13.00 Low Stock Price Target$13.00 Potential Upside/Downside+124.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.71) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,490,000.00 Net Margins-338.51% Pretax Margin-338.46% Return on Equity-54.49% Return on Assets-48.52% Debt Debt-to-Equity Ratio0.01 Current Ratio4.96 Quick Ratio4.83 Sales & Book Value Annual Sales$2.02 million Price / Sales31.75 Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book7.92Miscellaneous Outstanding Shares11,106,000Free Float5,099,000Market Cap$64.19 million OptionableNot Optionable Beta1.12 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (NASDAQ:NTRB) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Tax Shock?Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutriband Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutriband With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.